Dr Wendy Ingram
Profiles

Dr Wendy Ingram

Trial Manager

Clinical Trials & Health Research - Institute of Translational & Stratified Medicine (Faculty of Medicine and Dentistry)

Role

Clinical Trials Manager for Peninsula Clinical Trials Unit

Qualifications

PhD Pharmacokinetic and pharmacodynamic modelling of subcutaneous apomorphine in the treatment of idiopathic Parkinson's disease

BSC (Hons) Biomedical Technology

Professional membership

UK Trial Managers Network

Research interests


Randomised controlled trials:
e-coachER: Web support for exercise referrals 
The TACIT Trial: Tai Chi for people with dementia
NoPac: Novel use of Tranexamic Acid to reduce the need for nasal packing in epistaxis
REVERT: Evaluation of modified Valsalva effectiveness in re-entrant tachycardias
DIAT: Efficacy of a patient-orientated agenda for use in the diabetes clinical consultation
CAMS: Cannabinoids in multiple sclerosis
 
Other studies:
The SWIMS Project: Prospective longitudinal study of multiple sclerosis in South West England



Key publications are highlighted

Journals
Articles
Nyman SR, Hayward C, Ingram W, Thomas P, Thomas S, Vassallo M, Raftery J, Allen H & Barrado-Martín Y 2018 'A randomised controlled trial comparing the effectiveness of tai chi alongside usual care with usual care alone on the postural balance of community-dwelling people with dementia: protocol for the TACIT trial (TAi ChI for people with demenTia)' BMC Geriatrics 18, (1) 263-263 Author Site , DOI PEARL
Ingram W, Webb D, Taylor RS, Anokye N, Yardley L, Jolly K, Mutrie N, Campbell JL, Dean SG 2018 'Multicentred randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support in individuals with metabolic, musculoskeletal and mental health conditions: protocol for the e-coachER trial' BMJ Open 8, (9) Author Site , DOI PEARL
Ukoumunne OC, Vaidya B, Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A 2017 'A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study' BMJ Open 7, (3) e013519-e013519 , DOI PEARL
Frost J, Anderson R, Argyle C, Daly M, Harris-Golesworthy F, Harris J, Gibson A, Ingram W, Pinkney J 2013 'A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)' BMJ Open 3, (7) e003396-e003396 , DOI PEARL
Freeman J, Walters R, Ingram W, Slade A, Hobart J & Zajicek J 2013 'Evaluating change in mobility in people with multiple sclerosis: relative responsiveness of four clinical measures' Mult Scler 19, (12) 1632-1639 Author Site , DOI
2011 'Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis' Nature 476, (7359) 214-219 , DOI PEARL
Zajicek JP, Ingram WM, Vickery J, Creanor S, Wright DE & Hobart JC 2010 'Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort' BMC Neurol 10, Author Site , DOI PEARL
Ingram WM, Priston MJ & Sewell GJ 2006 'Improved assay for R(−)-apomorphine with application to clinical pharmacokinetic studies in Parkinson's disease' Journal of Chromatography B 831, (1-2) 1-7 , DOI
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP 2006 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Baron R, Ingram W, Warner M, Vickery PJ, Wright DE, Zajicek J & Hobart JC 2006 'Meaningless statistics and the illusion of fatigue' Journal of Neurology Neurosurgery and Psychiatry 77, (1)
Hobart, Riazi A, Styles IM & Thompson AJ 2005 'Getting the measure of spasticity in Multiple Sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS - 89)' Brain 129, (1) 224-234 , DOI
Zajicek JP, Sanders HP, Wright DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ 2005 'Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up' J Neurol Neurosurg Psychiatry 76, (12) 1664-1669 Author Site , DOI
Baron R, Zajicek J, Wright D, Vickery J, Ingram W & Hobart J 2005 'Confounding the confused: is measuring the frequency and severity of cognitive impairment really necessary?' Multiple Sclerosis 11, S68-S68
Hobart JC, Riazi A, Thompson AJ, Styles IM, Ingram W, Vickery PJ, Warner M, Fox PJ & Zajicek JP 2005 'Getting the measure of spasticity in MS: The Multiple Sclerosis Spasticity Scale (MSSS-88)' Journal of the Neurological Sciences 238, S229-S229
Zajicek J, Fox R, Teare L, Sanders H, Wright D, Vickery J, Ingram W, Reilly S, Nunn A, et. al 2004 'Cannabinoids in multiple sclerosis (CAMS) study, follow-up data suggesting an effect on disease progression' Journal of Neurology 251, 44-44
Ingram WM, Priston MJ & Sewell GJ 1999 'Dose optimisation for amorphine in Parkinson's disease: Pharmacokinetic-pharmacodynamic (PK-PD) studies' Journal of Pharmacy and Pharmacology 51, (SUPPL.)
Conference Papers
Warner M, Baron RA, Ingram WM, Vickery PJ, Reilly S, Wright DE, Zajicek JP & Hobart JC 2006 'Does the GHQ-30 leave room for change?' 134-134
Ingram WM, Hobart JC, Reilly SM, Vickery PJ, Wright DE & Zajicek JP 2006 'Introducing the south west impact of multiple sclerosis (SWIMS) project: A population-based natural history project to acquire patient-orientated information about the impact of multiple sclerosis' 131-131